文献速递血栓与止血

妊娠期血小板减少症

Thrombocytopenia in pregnancy.
PubMed 文献 · Blood · 2017-06-21

妊娠期或产后早期约5%至10%的女性发生血小板减少。本章基于就诊孕周、血小板减少严重程度及临床实验室表现,帮助血液科会诊医生鉴别诊断,并为常见诊疗决策提供指导。

要点

  • 妊娠期或产后早期5%至10%女性发生血小板减少,常为偶然发现。
  • 血小板减少可能是系统性或妊娠期疾病的生物标志物。
  • 管理需基于孕周、血小板减少严重程度及临床实验室表现进行鉴别诊断。

核心结论

  • 本章旨在帮助血液科会诊医生基于孕周、血小板减少严重程度及临床实验室表现鉴别妊娠期血小板减少,并为常见诊疗决策提供指导。

研究设计与样本

  • 本章为综述,反映作者对妊娠期血小板减少症的诊疗思路,重点总结过去5至10年在常见病因认识与管理方面的进展。

主要发现

  • 妊娠期或产后早期5%至10%的女性发生血小板减少。
  • 免疫性血小板减少症管理趋势使更多女性在接受血小板生成素受体激动剂、利妥昔单抗或麦考酚酯治疗期间考虑妊娠,这些药物对胎儿有已知或未知风险。
  • 诊断子痫前期的新标准、对ADAMTS13检测的审慎依赖以指导疑似血栓性血小板减少性紫癜的管理决策、支持抗补体治疗妊娠期非典型溶血性尿毒症综合征有效性和安全性的新证据,以及血栓性微血管病对后续妊娠的影响正在快速演变。

临床怎么用

  • 本章未给出具体推荐等级或剂量方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the immediate postpartum period. A low platelet count is often an incidental feature, but it might also provide a biomarker of a coexisting systemic or gestational disorder and a potential reason for a maternal intervention or treatment that might pose harm to the fetus. This chapter reflects our approach to these issues with an emphasis on advances made over the past 5 to 10 years in understanding and managing the more common causes of thrombocytopenia in pregnancy. Recent trends in the management of immune thrombocytopenia translate into more women contemplating pregnancy while on treatment with thrombopoietin receptor agonists, rituximab, or mycophenylate, which pose known or unknown risks to the fetus. New criteria to diagnose preeclampsia, judicious reliance on measurement of ADAMTS13 to make management decisions in suspected thrombotic thrombocytopenic purpura, new evidence supporting the efficacy and safety of anticomplement therapy for atypical hemolytic uremic syndrome during pregnancy, and implications of thrombotic microangiopathies for subsequent pregnancies are evolving rapidly. The goals of the chapter are to help the hematology consultant work through the differential diagnosis of thrombocytopenia in pregnancy based on trimester of presentation, severity of thrombocytopenia, and coincident clinical and laboratory manifestations, and to provide guidance for dealing with some of the more common and difficult diagnostic and management decisions.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Cines DB, Levine LD. Thrombocytopenia in pregnancy. Blood. 2017. PMID: 28637667. doi:10.1182/blood-2017-05-781971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。